SWOG 1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Crossed-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer

CTO - 7548
Cancer - Gastro/ Esophageal
  1. Males and females at least 18 years of age
  2. Confirmed esophageal, stomach, or GEJ cancer; HER-2 negative with available tumor
Open
Tiffany Pearce